A detailed history of Silvercrest Asset Management Group LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 267,604 shares of ATRC stock, worth $9.56 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
267,604
Previous 269,144 0.57%
Holding current value
$9.56 Million
Previous $6.13 Million 22.44%
% of portfolio
0.05%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.34 - $29.5 $31,323 - $45,430
-1,540 Reduced 0.57%
267,604 $7.5 Million
Q2 2024

Aug 14, 2024

SELL
$19.86 - $29.09 $5.35 Million - $7.83 Million
-269,144 Reduced 50.0%
269,144 $6.13 Million
Q2 2024

Aug 14, 2024

BUY
$19.86 - $29.09 $6.91 Million - $10.1 Million
347,738 Added 182.49%
538,288 $12.3 Million
Q1 2024

May 15, 2024

SELL
$28.21 - $37.78 $1.9 Million - $2.54 Million
-67,315 Reduced 26.1%
190,550 $5.8 Million
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $1.82 Million - $2.38 Million
55,115 Added 27.18%
257,865 $9.2 Million
Q3 2023

Nov 14, 2023

SELL
$41.12 - $57.73 $2 Million - $2.81 Million
-48,636 Reduced 19.35%
202,750 $8.88 Million
Q2 2023

Aug 14, 2023

BUY
$40.44 - $49.6 $1.52 Million - $1.86 Million
37,506 Added 17.54%
251,386 $12.4 Million
Q1 2023

May 15, 2023

SELL
$35.87 - $47.22 $6,600 - $8,688
-184 Reduced 0.09%
213,880 $8.87 Million
Q4 2022

Feb 14, 2023

SELL
$33.48 - $47.45 $109,345 - $154,971
-3,266 Reduced 1.5%
214,064 $9.5 Million
Q3 2022

Nov 14, 2022

SELL
$38.25 - $52.62 $206,091 - $283,516
-5,388 Reduced 2.42%
217,330 $8.5 Million
Q2 2022

Aug 15, 2022

BUY
$35.1 - $66.01 $2.53 Million - $4.77 Million
72,191 Added 47.96%
222,718 $9.1 Million
Q1 2022

May 16, 2022

BUY
$57.43 - $71.39 $101,823 - $126,574
1,773 Added 1.19%
150,527 $9.89 Million
Q4 2021

Feb 14, 2022

BUY
$63.4 - $87.14 $47,867 - $65,790
755 Added 0.51%
148,754 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$69.28 - $84.46 $227,307 - $277,113
-3,281 Reduced 2.17%
147,999 $10.3 Million
Q2 2021

Aug 16, 2021

SELL
$64.13 - $80.18 $2.82 Million - $3.53 Million
-44,050 Reduced 22.55%
151,280 $12 Million
Q1 2021

May 17, 2021

SELL
$53.79 - $66.98 $1.42 Million - $1.77 Million
-26,402 Reduced 11.91%
195,330 $12.8 Million
Q4 2020

Feb 16, 2021

BUY
$34.56 - $57.55 $209,675 - $349,155
6,067 Added 2.81%
221,732 $12.3 Million
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $1.72 Million - $2.1 Million
44,720 Added 26.16%
215,665 $8.61 Million
Q2 2020

Aug 14, 2020

SELL
$31.78 - $51.19 $1.42 Million - $2.29 Million
-44,831 Reduced 20.78%
170,945 $7.68 Million
Q1 2020

May 15, 2020

SELL
$24.49 - $43.84 $935,346 - $1.67 Million
-38,193 Reduced 15.04%
215,776 $7.25 Million
Q4 2019

Feb 14, 2020

SELL
$24.06 - $32.51 $1.61 Million - $2.17 Million
-66,743 Reduced 20.81%
253,969 $8.26 Million
Q3 2019

Nov 14, 2019

BUY
$23.81 - $32.52 $7.64 Million - $10.4 Million
320,712 New
320,712 $8 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.66B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.